Cumberland Pharmaceutical... (CPIX)
undefined
undefined%
At close: undefined
2.44
1.67%
After-hours Dec 13, 2024, 07:59 PM EST

Company Description

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally.

The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.

It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis.

In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension.

Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate that is in Phase II clinical trial for cholesterol reducing agent to use in the hospital setting.

The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc. logo
Country United States
IPO Date Aug 11, 2009
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 91
CEO A. J. Kazimi MBA

Contact Details

Address:
2525 West End Avenue
Nashville, Tennessee
United States
Website https://www.cumberlandpharma.com

Stock Details

Ticker Symbol CPIX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001087294
CUSIP Number 230770109
ISIN Number US2307701092
Employer ID 00-0000000
SIC Code 2834

Key Executives

Name Position
A. J. Kazimi MBA Founder, Chairman, President & Chief Executive Officer
John Michael Hamm C.M.A. Vice President & Chief Financial Officer
Adam S. Mostafa Managing Director
Chris T. Bitterman Vice President of Sales & Marketing
Erin Smith Gull Senior Corporate Relations Associate
James Lowrance Herman Executive Vice President of National Accounts & Chief Compliance Officer
Jean W. Marstiller Senior Vice President of Administrative Services & Corporate Secretary
Todd M. Anthony Vice President of Organizational Development

Latest SEC Filings

Date Type Title
Dec 09, 2024 8-K Current Report
Dec 05, 2024 4 Filing
Dec 05, 2024 4 Filing
Dec 05, 2024 4 Filing
Dec 05, 2024 4 Filing
Nov 08, 2024 10-Q Quarterly Report
Nov 07, 2024 8-K Current Report
Nov 06, 2024 8-K Current Report
Nov 05, 2024 4 Filing
Nov 05, 2024 4 Filing